Every year brings its own distinct changes. For the life sciences industry, 2022 was marked by challenges such as the ongoing influence of the pandemic, a turbulent economy and a shrinking biotech bubble — along with positive momentum around DE&I and the continued integration of paradigm-shifting tech.
Here’s a look at how industry leaders are navigating the key issues of 2023.
